Medtech Talk
Medtech Talk
Healthegy
CEO Stevens Says HeartFlow Took No Shortcuts to Commercialization, Raising $240 million Series E
35 minutes Posted Mar 6, 2018 at 5:00 am.
0:00
35:16
Download MP3
Show notes
John H. Stevens, MD, was too excited to sleep when he first heard what HeartFlow's technology could potentially do. Eight years later, he's sleeping a lot better, having secured $240 million to fund the company's commercial rollout of the HeartFlow Analysis system.

Overview: HeartFlow has built a strong financial argument for its imaging system.

Surprises: This stuff belongs on Star Trek. Very cool.

Takeaway: "There are no shortcuts."